House Subcommittee Will Examine Healthcare Fraud, Competition

The House Judiciary Committee's subcommittee will hold a hearing on September 14 to examine healthcare fraud and competition, reflecting intensified federal and state regulatory scrutiny on pricing algorithms, market consolidation, and enforcement actions against fraud. This follows aggressive enforcement by the FTC and state regulators targeting mergers, rebate practices, and private equity involvement in healthcare markets to address inflated costs and reduce anti-competitive behaviour.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure.